Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies 20.03 ->
PRESS RELEASE: InvestEU: EIB agrees to €18 million loan to Estonian biotech Icosagen for innovative R&D technologies and new cGMP production facility 08.02 ->
